Clinical trials
Language Disorders trials in the United States with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
29 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2009 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2020 | 4 |
| 2021 | 3 |
| 2022 | 4 |
| 2023 | 4 |
| 2024 | 2 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 17 |
| Recruiting | 7 |
| Unknown status | 2 |
| Active, not recruiting | 1 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Oregon Health and Science University | 2 |
| Shirley Ryan AbilityLab | 2 |
| US Department of Veterans Affairs | 2 |
| University of Houston | 2 |
| Vanderbilt University | 2 |
| Altec Inc. | 1 |
| Arizona State University | 1 |
| Boston University Charles River Campus | 1 |
| Casa Colina Hospital and Centers for Healthcare | 1 |
| Father Flanagan's Boys' Home | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Language Disorders | 29 |
| Aphasia | 11 |
| Language Development Disorders | 9 |
| Stroke | 6 |
| Communication Disorders | 5 |
| Speech Disorders | 4 |
| Aphasia, Primary Progressive | 2 |
| Apraxias | 2 |
| Cerebral Palsy | 2 |
| Down Syndrome | 2 |
Trials
Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.